Cardiac stem cell infusions could someday help reverse the aging process in the human heart, making older ones behave younger, according to a new study from the Cedars-Sinai Heart Institute.
Biotronik’s Home Monitoring is an award-winning remote cardiac monitoring system that automatically collects data from a patient’s cardiac device, enabling the physician to review cardiac function independently of in-office visits.
Cardiology in extreme environments takes centre stage at the British Cardiovascular Society (BCS) annual conference.
Professionals in the field of children’s cardiology will hold their world congress in FCB’s Camp Nou, Barcelona, Spain from the 16th to the 21st of July 2017. As part of the congress and for the first time, a special symposium will unite leading experts in the field of sports cardiology to discuss the heart health of the sports stars of the future.
Arteriogenesis is a critical event – not only during development but also in adult life. Many Cardiovascular life-threatening events could be overcome by inducing the formation of new arteries. A team of scientists led by Ralf Adams from the Max Planck Institute for Molecular Biomedicine has developed a genetic approach in mice to uncover molecular mechanisms of arterial growth.
The EASY PULSE® is an unbelievably small and light mechanical chest compression device. Performing manual chest compressions well for an extended period of time is almost impossible. Not only is it physically demanding, but other actions, such as vital signs monitoring, are also required simultaneously. SCHILLER’s EASY PULSE® is the solution for more efficient resuscitation: this portable,…
The ADVIA Centaur® High-Sensitivity Troponin I (TNIH) assay* is the latest addition to Siemens Healthineers’ comprehensive cardiac menu to assist clinicians with the diagnosis and treatment of chest pain patients. Designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma, high-sensitivity troponin plays a…
Breast implants may impede an electrocardiogram (ECG) and could result in a false heart attack diagnosis, according to research by the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC).
Researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have engineered a three-dimensional heart tissue from human stem cells to test the safety and efficacy of new drugs on the heart.
Cardiac surgeons are successfully performing more extensive surgical repairs of type A aortic dissection—one of the highest risk operations in cardiothoracic surgery. These new surgical techniques, along with improved postoperative care, are resulting in better long-term outcomes and lower rates of complications.
Researchers in Japan have identified a receptor protein on the surface of heart cells that promotes chronic heart failure. The study, “Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction” suggests that inhibiting this protein could help treat a disease that affects more than 20 million people worldwide.
Research published in Experimental Physiology shows that diabetes-induced changes in heartbeat are primarily regulated by the β1-adrenoceptor. This discovery, once confirmed in humans, may lead to better treatment of heart problems in diabetics by enabling more targeted drugs to be produced.
Researchers have found that people with A, B, and AB blood types may be at greater risk of cardiovascular events - particularly heart attack - than individuals with O blood types.
Researchers who studied beer drinkers at the Munich Oktoberfest have found that the more alcohol consumed the higher was the likelihood of developing abnormal heart rhythms called cardiac arrhythmias.
MBM ScienceBridge GmbH successfully negotiated a license agreement between Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin (UMG) and the biotech company Repairon GmbH about commercial production and use of engineered human myocardium for heart failure repair. The production methods are based on the scientific work from the group of Prof. Dr.…
Cardiology at the extremes will be the key theme at the British Cardiovascular Society annual conference in Manchester in June. Topics covered include reflections in cardiology and space travel, physiological challenges associated with living under extreme environmental conditions and polar expeditions.
Report: Mark Nicholls
Space missions are famous for driving innovation, from Mylar blankets to microchips. So when French scientists learned one of their compatriots would be aboard the Soyuz MS-03 spacecraft to reach the International Space Station (ISS), they gathered cutting edge technologies for him to carry into orbit.
Researchers are revisiting their views on the relative dangers soft and hard atherosclerotic plaque deposits pose to heart health. Findings of a new study by researchers at the Intermountain Medical Center Heart Institute may be a “game-changer” for determining who’s at risk of a heart attack, they say.
Agfa HealthCare announces that it is releasing a new version of its Enterprise Imaging for Cardiology platform at the American College of Cardiologists' ACC.17 expo. Customer-driven enhancements include new structured reporting modules for congenital echocardiology and nuclear cardiology.
Royal Philips today announced that the results from two large clinical trials comparing patient outcomes using instant wave-free ratio (iFR) and fractional flow reserve (FFR) in the diagnosis and treatment of heart disease have been published in the New England Journal of Medicine. First released in 2013, iFR is an innovative pressure-derived index unique to Philips, a global leader in…
The ProMRI Configurator made by Biotronik is an online tool that enables physicians to select from a series of MRI requirements for a patient and subsequently generates a recommendation of all suitable MR-conditional cardiac device and lead combinations available in a particular country, thus helping physicians to choose the most suitable MR-conditional cardiac systems for each patient.
‘Youth’ is the central theme of this year’s ECR. More than 25,000 delegates from over 100 countries are expected for the 29th conference at the Vienna’s Austria Centre to take part in the annual meeting that promotes science and innovation.
RDT, a leading provider of pre-hospital care solutions, will be previewing its Tempus ALS™ monitor defibrillator at Arab Health 2017. Visitors to Stand Z1A59 will be able to see this innovative solution – which offers the benefits of a fully ERC-compliant defibrillator and an advanced monitor in a small and lightweight package – ahead of its official launch later in the year.
UK scientists are developing an interactive holographic video created from an MRI or CT scan that can display live footage of internal organs in front of a user where features can be rotated, enlarged, and isolated, delivering a breakthrough in medical imaging and education.
Remote Diagnostic Technologies Ltd (RDT) previewed its Tempus ALS™ monitor defibrillator at MEDICA 2016, ahead of its official launch in early 2017. Tempus ALS offers the benefits of a fully ERC-compliant defibrillator and an advanced monitor in a small and lightweight package.
